Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Aug 7, 2014, after the close
10-Q filed Aug 7, 2014, 38 days after period end · 0001171843-14-003812
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $26.96M | $26.09M | $28.50M | $27.14M |
| Net Income | $1.02M | -$186.00K | $774.00K | $1.37M |
| EPS Diluted | $0.03 |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.01 |
| $0.02 |
| $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
